VESOMNI

This brand name is authorized in Austria, Brazil, Spain, Croatia, Ireland, Netherlands, Poland, Romania, United Kingdom

Active ingredients

The drug VESOMNI contains a combination of these active pharmaceutical ingredients (APIs):

1 Solifenacin
UNII KKA5DLD701 - SOLIFENACIN SUCCINATE

Solifenacin is a competitive, specific cholinergic-receptor antagonist. In vitro and in vivo pharmacological studies indicate that solifenacin is a competitive inhibitor of the muscarinic M3 subtype receptor.

Read about Solifenacin
2 Tamsulosin
UNII 11SV1951MR - TAMSULOSIN HYDROCHLORIDE

Tamsulosin binds selectively and competitively to post-synaptic α1-adrenoreceptors, prevailingly their subtypes designated α1A and α1D. Thus relaxation of smooth muscles of the prostate and urethra is achieved, which leads to a reduction of tonus and an improvement of the urinary flow.

Read about Tamsulosin

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
VESOMNI Modified release tablets Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
G04CA53 G Genito urinary system and sex hormones → G04 Urologicals → G04C Drugs used in benign prostatic hypertrophy → G04CA Alpha-adrenoreceptor antagonists
Discover more medicines within G04CA53

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 540315010002405, 540315010002505
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 78607
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 236751, 377371, 381737
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-310582492
Country: IE Health Products Regulatory Authority Identifier(s): 34589, 34594, 34598
Country: NL Z-Index G-Standaard, PRK Identifier(s): 105724
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100327666
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W68606001, W68606002, W68606003, W68606004, W68606005, W68606006, W68606007, W68606008, W68606009, W68606010, W68606011

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.